The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus.

Persons

Gail H Cassell

Venue / Journal

iScience

Date

Fri, 09/27/2019 - 12:00

Additional Journal Information

19:1279-1290

Authors

Jasenosky LD, Cadena C, Mire CE, Borisevich V, Haridas V, Ranjbar S, Nambu A, Bavari S, Soloveva V, Sadukhan S, Cassell GH, Geisbert TW, Hur S, Goldfeld AE.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/31402258